Affordable Access

Antagonism of estrogen action with a new benzothiophene derived antiestrogen.

Authors
  • Black, L J
  • Jones, C D
  • Falcone, J F
Type
Published Article
Journal
Life Sciences
Publisher
Elsevier
Publication Date
Feb 28, 1983
Volume
32
Issue
9
Pages
1031–1036
Identifiers
PMID: 6827921
Source
Medline
License
Unknown

Abstract

A new benzothiophene derived antiestrogen, LY139481, inhibited the uterotropic action of estradiol in a dose related fashion, and at 1 mg per day suppressed more than 90 percent of estradiol's activity in immature rats. LY139481 induced minimal uterotropic activity, and that activity declined in relation to dose. The relative binding affinity of LY139481 for rat uterine cytosol estrogen receptors was greater than that of estradiol in competitive assays and increased in relation to temperature (2.9 +/- 0.5 x estradiol at 30 degrees C). LY139481 caused estradiol-induced uterine hypertrophy to regress in a manner similar to that which resulted from withdrawal of estradiol treatment. Three successive daily injections of LY139481 slightly increased uterine weight, and blocked additional uterotropic action in response to estradiol and LY139481 administration on subsequent days. Furthermore, ten daily injections of estradiol alone did not increase uterine weight in animals pretreated with LY139481 for three days. In contrast, LY139481 did not prevent the partial uterotropic action of tamoxifen administration.

Report this publication

Statistics

Seen <100 times